2.1. Analysis.
Comparison 2: Long‐term therapeutic dose oral anticoagulation for atrial fibrillation (start versus avoid), Outcome 1: All major adverse cardiovascular events (MACE)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.